Summary of Proceedings of Thirty Third (33rd) AGM of the Company along with Voting Results and Scrutinizers Report.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Titan Biotech Ltd held its 33rd AGM on September 26, 2025, from 3:00 PM to 3:58 PM via video conferencing. Out of 16,425 total shareholders on record, 236 attended through VC (9 promoter group and 227 public). All 15 resolutions were passed with the requisite majority, including adoption of audited standalone and consolidated financial statements for FY2024-25, declaration of dividend on equity shares, and reappointment of directors Mrs. Manju Singla, Mr. Raja Singla, and Mr. Udit Singla. Special resolutions were approved for the reappointment of Managing Directors Mr. Naresh Kumar Singla and Mr. Suresh Chand Singla, an increase in remuneration for Whole Time Directors Mr. Shivom Singla and Mr. Udit Singla, regularization of independent director Mr. Debendra Kumar Sabat, authorization for loans, mortgage of company property for borrowings, and approval of material related party transactions. Most resolutions received over 99% approval, with the two related-party and loan resolutions showing slightly lower support at 91.43%. The scrutinizer's report confirmed all votes were cast validly.
Shareholders have approved a dividend (specific amount not disclosed in the filing), reappointed all key directors and managing directors, and sanctioned increased pay for some executive directors. The high pass percentage on routine resolutions and reappointments signals stable management continuity, though the relatively lower (~91.4%) approval on related-party transactions and loan authorizations reflects some shareholder dissent on those items.